Indiana University

Indiana University

Indiana University

Overview
Date Founded

1820

Headquarters

107 S INDIANA AVE, BLOOMINGTON, IN, 47405, USA

Charitable Causes

Higher Education & Universities
Education Research & Support

Employees (Worldwide)

16K

Industries

Investment Services & Portfolio Management
Trusts & Funds

Company Description

Indiana University is a major multi-campus public research institution, grounded in the liberal arts and sciences, and a world leader in professional, medical, and technological education. Indiana University’s mission is to provide broad access to undergraduate, graduate, and continuing education for students throughout Indiana, the United States, and the world, as well as outstanding academic and cultural programs and student services. Indiana University seeks to create dynamic partnerships with the state and local communities in economic, social, and cultural development and to offer leadership in creative solutions for 21st century problems. Indiana University strives to achieve full diversity, and to maintain friendly, collegial, and humane environments, with a strong commitment to academic freedom.

Contact Data
Trying to get in touch with decision makers at Indiana University? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

President

Vice President & Chief Financial Officer

Founder

Owner

Owner

Owner

Owner

Board of Trustees

Director at Indiana University Foundation

Co-Founder at The Gill Foundation

Member, Board of Trustees at Indiana University

Fiduciary Director at Indiana University Foundation

Member, Board of Trustees at Indiana University

Director at Indiana University Foundation

Assistant Professor of Medicine & Biochemistry at Indiana University

Distinguished Alumni
Ronald Kruszewski is now Chief Executive Officer at Stifel Financial Corp.
Barry M. Gosin is now Chief Executive Officer at Newmark Group, Inc.
David Simon is now Chairman, Chief Executive Officer & President at Simon Property Group, Inc.
Paths to Indiana University
Potential Connections via
Relationship Science
You
Indiana University
Advisors & Consultants
Advisor

Chairman at Lipman Hearne, Inc.

Legal Advisor

Practice Group Chair & Partner at Taft Stettinius & Hollister LLP

Consultant

Senior Consulting Vice President at Grenzebach Glier & Associates, Inc.

Clients

Ventrus Biosciences, Inc. is a development stage specialty pharmaceutical company engages in development of late-stage prescription drugs for gastrointestinal disorders, specifically hemorrhoidal disease, anal fissures, and fecal incontinence. Its major pharmaceutical progress made in the gastrointestinal therapeutic areas of gastroesophageal reflux, peptic ulcer disease, and inflammatory bowel disease. Ventrus Biosciences products includes VEN 307 (topical diltiazem), is intended to treat pain associated with anal fissures and VEN 308 (topical phenylephrine), is intended to treat fecal incontinence. The company was founded on October 10, 2005 and is headquartered in New York, NY.

Key Stats and Financials As of 2020
Market Capitalization
Total Enterprise Value
Earnings Per Share
Revenue
$2.26B
Non-Profit Donations & Grants
Non-Profit Donations & Grants Received
Awards & Honors
Rank #65
2010
The Chronicle of Philanthropy - Philanthropy 400
Rank #38
2009
The Chronicle of Philanthropy - Philanthropy 400
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Indiana University. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Indiana University's profile does not indicate a business or promotional relationship of any kind between RelSci and Indiana University.